SKK
CRTX

Shepherd Kaplan Krochuk’s CORNERSTONE THERAPEUTICS INC CRTX Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio CRTX Stock Details CRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-26,599
Closed -$250K – 690
2013
Q3 		$250K Buy
+26,599
New +$240K 0.04% 376

Other funds holding CRTX

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HA
Havens Advisors New York $39.3M AUM 80.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LIM
Longfellow Investment Management Boston, Massachusetts $480M AUM 8% 1-Year Est. Return

Shepherd Kaplan Krochuk's CRTX Position: Q4 2013 in Review

Shepherd Kaplan Krochuk sold out of CORNERSTONE THERAPEUTICS INC (CRTX) in Q4 2013, closing a stake of 26,599 shares — an estimated $250K sold.

Shepherd Kaplan Krochuk first reported a position in CRTX in Q3 2013 and held it in 1 quarter. The position peaked at $250K in Q3 2013. 62 funds tracked by Wall St. Rank hold CRTX as of Q4 2013.

  • Shepherd Kaplan Krochuk reported no remaining CORNERSTONE THERAPEUTICS INC position as of Q4 2013 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 26,599 CORNERSTONE THERAPEUTICS INC shares in Q4 2013, an estimated $250K.
  • Shepherd Kaplan Krochuk first reported a position in CORNERSTONE THERAPEUTICS INC in Q3 2013 and held it in 1 quarter.
  • Shepherd Kaplan Krochuk's CORNERSTONE THERAPEUTICS INC position peaked at $250K in Q3 2013.
  • 62 funds tracked by Wall St. Rank held CORNERSTONE THERAPEUTICS INC as of Q4 2013.

Based on Shepherd Kaplan Krochuk's 13F filing for Q4 2013, filed 14 Feb 2014.